Home » Stocks » TEVA

Teva Pharmaceutical Industries Ltd. (TEVA)

Stock Price: $10.36 USD 0.09 (0.83%)
Updated May 13, 2021 3:07 PM EDT - Market open
Market Cap 11.61B
Revenue (ttm) 16.28B
Net Income (ttm) -3.98B
Shares Out 1.10B
EPS (ttm) -3.63
PE Ratio n/a
Forward PE 3.97
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $10.36
Previous Close $10.27
Change ($) 0.09
Change (%) 0.83%
Day's Open 10.33
Day's Range 10.25 - 10.52
Day's Volume 5,055,511
52-Week Range 8.44 - 13.30

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that it will present two new e-...

3 days ago - Business Wire

Francisco Garcia Parames (Trades, Portfolio), founder and leader of Spanish investment firm Cobas Asset Management, disclosed his first-quarter portfolio earlier this week.

Other stocks mentioned: GIII
6 days ago - GuruFocus

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2020 Environmental, Social and Governance (ESG) Progress Report detailing the company's e...

1 week ago - Business Wire

With the trading day more than halfway over, the broad markets were getting crushed.

Other stocks mentioned: EDIT, RBLX, X
1 week ago - 24/7 Wall Street

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of its 250 mg and 50...

1 week ago - Business Wire

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data from the 3-year open-l...

1 week ago - Business Wire

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced its launch of the first availab...

1 week ago - Business Wire

TEVA beats on first-quarter earnings and sales. Sales & profits decline year over year.

2 weeks ago - Zacks Investment Research

Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) CEO said that its offers to help manufacture coronavirus vaccines were turned down by major vaccine makers, despite having production capacity ready to ...

2 weeks ago - Benzinga

Increased competition for several of its top products continued to affect the drugmaker's performance in Q1.

2 weeks ago - The Motley Fool

Israel's Teva Pharmaceutical Industries is not likely to reach deals with COVID vaccine makers to co-produce the vaccines although discussions are still ongoing, chief executive Kare Schultz told Reuters.

2 weeks ago - Reuters

Israel-based Teva Pharmaceutical Industries reported first-quarter profit that met estimates on Wednesday and said it was on track to meet its 2021 targets due to growth in Huntington's disease treatmen...

2 weeks ago - Reuters

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the quarter ended March 31, 2021. Mr. Kåre Schultz, Teva's President and CEO, said...

2 weeks ago - Business Wire

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced four new posters examining long...

2 weeks ago - Business Wire

TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the launch of its 1000 mg str...

2 weeks ago - Business Wire

Four drugmakers helped cause the deadly U.S. opioid epidemic by deceptively marketing their drugs and downplaying their addictive risks, a lawyer for several California counties argued on Monday at the ...

Other stocks mentioned: JNJ, ABBV, ENDP
3 weeks ago - Reuters

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced 19 presentations exam...

4 weeks ago - Business Wire

3 Generic Drug Stocks to Watch Amid COVID-Related Recovery

Other stocks mentioned: AMPH, BHC, RDY
4 weeks ago - Zacks Investment Research

MONTRÉAL--(BUSINESS WIRE)--AJOVY® now offers patients greater flexibility with two dosing options available in both an autoinjector and a prefilled syringe.

1 month ago - Business Wire

AMSTERDAM--(BUSINESS WIRE)--Teva Pharmaceuticals Europe announced that it has received EU Marketing Authorisation for Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/ flutica...

1 month ago - Business Wire

With the trading day approaching halfway over, the broad markets were trading marginally positive.

Other stocks mentioned: ANF, PFE, DHR, FLXN, JAZZ
1 month ago - 24/7 Wall Street

TEL AVIV--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its financial results for the first quarter on Wednesday, April...

1 month ago - Business Wire

TORONTO--(BUSINESS WIRE)--Teva Canada today unveiled new resources and programming to support the mental health challenges caregivers often experience.

1 month ago - Business Wire

Building wealth is easy when you own great businesses.

Other stocks mentioned: KL, OGI, PING, SIRI
1 month ago - The Motley Fool

Value stocks have historically outperformed during economic recoveries -- and these companies look poised to shine under the new administration.

Other stocks mentioned: FB, GT, SSRM
1 month ago - The Motley Fool

TEL AVIV & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced its launch of the first availa...

2 months ago - Business Wire

These deeply discounted stocks are perfect for patient investors.

Other stocks mentioned: AGNC, SSRM
2 months ago - The Motley Fool

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Executive Vice President & CFO Eli Kalif will present at the J.P. Morgan 2021 Global Hig...

2 months ago - Business Wire

The largest generic drug manufacturer in the world can be bought for pennies on the dollar.

2 months ago - The Motley Fool

If you're looking for stability or growth, look elsewhere.

Other stocks mentioned: USPH
2 months ago - The Motley Fool

TEVA beats on fourth-quarter earnings and sales. It issues its financial guidance for 2021.

3 months ago - Zacks Investment Research

Even though the market has been on fire recently, that doesn't mean you're too late to pick up cheap stocks under $20 with 2x (or more) potential. The post 8 Cheap Stocks Under $20 That Could Double app...

Other stocks mentioned: BGFV, CLDR, CRLBF, MMEDF, PRTS, SSRM, STKL
3 months ago - InvestorPlace

Teva in Talks to Help Make Covid Vaccines, CEO Says

YouTube video

Feb.10 -- Teva Pharmaceutical Industries Ltd. Chief Executive Officer Kare Schultz discusses the company's plans to produce and distribute Covid-19 vaccines and says Teva is ready to settle thousands of...

3 months ago - Bloomberg Markets and Finance

Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel

YouTube video

Teva Pharmaceuticals CEO Kare Schultz joins "Squawk on the Street" to discuss the rollout of Covid-19 vaccines in Israel. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://...

3 months ago - CNBC Television

TEVA beats earnings and sales for fourth-quarter 2020. It issues its financial guidance for 2021.

3 months ago - Zacks Investment Research

Shares of Teva Pharmaceutical Indus (NYSE:TEVA) moved higher by 3.7% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 9.68% over the past year to $0...

3 months ago - Benzinga

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today reported results for the year and the quarter ended December 31, 2020. Q4 2020 and FY 2020 highlights: ...

3 months ago - Business Wire

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...

3 months ago - Zacks Investment Research

On TEVA's fourth-quarter conference call, investors focus is likely to be on updates on the extent to which the resurgence of COVID-19 infection rates impacted sales of its products.

3 months ago - Zacks Investment Research

The conditions are ripe for a strong bull market to take shape under the new administration, and these ultracheap stocks could be direct beneficiaries.

Other stocks mentioned: AGNC, CVS, IBM, SSRM
3 months ago - The Motley Fool

Things are looking up for these beaten-down value plays in the new year.

Other stocks mentioned: KL, WBA
3 months ago - The Motley Fool

The shares of Teva Pharmaceutical Industries Ltd (NYSE:TEVA) are up 0.4% at $11.54 this morning, after the company announced plans to launch a generic version of Merck's (MRK) birth control device known...

3 months ago - Schaeffers Research

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals USA, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd.(NYSE and TASE: TEVA), today announced the availability of a ...

3 months ago - Business Wire

Teva Pharmaceutical Industries Limited (TEVA) CEO Kåre Schultz on 39th Annual JP Morgan Healthcare Conference Transcript

Other stocks mentioned: JPM
4 months ago - Seeking Alpha

With proper research and long-term investing, $1 million can easily be in reach. Check out these stocks that could make you a millionaire.

Other stocks mentioned: AAXN, BAND, CLDR, LOVE, LOW, SYNA
4 months ago - InvestorPlace

Bargains are plentiful for value investors in the new year.

Other stocks mentioned: AUY, EXEL, WBA, WFC
4 months ago - The Motley Fool

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2020 financial results...

4 months ago - Business Wire

TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that President & CEO Kåre Schultz will present at the 39th Annual J.P. Morgan Healthcare Conf...

4 months ago - Business Wire

TEL AVIV, Israel & PARIS--(BUSINESS WIRE)--Teva Pharmaceuticals Industries Ltd. (NYSE and TASE: TEVA) and MedinCell (Euronext: MEDCL) today announced positive results for study TV46000-CNS-30072 (the RI...

4 months ago - Business Wire

These time-tested Buffett holdings can pump up your portfolio.

Other stocks mentioned: AMZN, BRK.A, BRK.B, GOLD, WFC
4 months ago - The Motley Fool

About TEVA

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central... [Read more...]

Industry
Drug Manufacturers-Specialty & Generic
Founded
1901
CEO
Kaare Schultz
Employees
37,100
Stock Exchange
NYSE
Ticker Symbol
TEVA
Full Company Profile

Financial Performance

In 2020, TEVA's revenue was $16.66 billion, a decrease of -1.35% compared to the previous year's $16.89 billion. Losses were -$3.99 billion, 299.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 25 analysts, the average rating for TEVA stock is "Hold." The 12-month stock price forecast is 12.20, which is an increase of 17.82% from the latest price.

Price Target
$12.20
(17.82% upside)
Analyst Consensus: Hold